CN102919849A - Dietary supplement for lowering blood sugar and lowering cholesterol - Google Patents

Dietary supplement for lowering blood sugar and lowering cholesterol Download PDF

Info

Publication number
CN102919849A
CN102919849A CN2011102249814A CN201110224981A CN102919849A CN 102919849 A CN102919849 A CN 102919849A CN 2011102249814 A CN2011102249814 A CN 2011102249814A CN 201110224981 A CN201110224981 A CN 201110224981A CN 102919849 A CN102919849 A CN 102919849A
Authority
CN
China
Prior art keywords
lowering
cholesterol
blood sugar
dietary supplement
bitter buckwheat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011102249814A
Other languages
Chinese (zh)
Inventor
牛锐
田袭
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yongkang Pharmaceutical Co., Ltd., Chengdu
Original Assignee
YONGKANG PHARMACEUTICAL CO Ltd CHENGDU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by YONGKANG PHARMACEUTICAL CO Ltd CHENGDU filed Critical YONGKANG PHARMACEUTICAL CO Ltd CHENGDU
Priority to CN2011102249814A priority Critical patent/CN102919849A/en
Publication of CN102919849A publication Critical patent/CN102919849A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides a composition for lowering blood sugar and lowering cholesterol. Soybean phytosterol and tartary buckwheat with high safety are combined to prepare the dietary supplement suitable for daily drinking.

Description

A kind of dietary supplements for hypoglycemic norcholesterol
Technical field
The present invention relates to a kind of composition of hypoglycemic norcholesterol, belong to dietary supplements.
Background technology
Raising and the dietary structure of people's living standard change, and cause the people who suffers from hypertension, high fat of blood and hyperglycaemia day by day to increase, and angiocardiopathies such as " three height " becomes the killer of human health.
Clinical medicine for reducing cholesterol has several classes at present: Statins is trimethyl glutaryl coenzyme A (HMG-CoA) reductase inhibitor, suppresses synzyme; The special class of shellfish is that to suppress triglycerides be main; The nicotinic acid class belongs to vitamin B complex; Cholic acid chelating agent; Cholesterol absorption inhibitor is of little use.More or less there are some bad reactions in this five classes medicine.
At present clinical have several classes for hypoglycemic medicine: Drugs Promoting Insulin Secretion is to promote insulin secretion and work, and commonly used have sulfonylureas, non-sulfonylureas and a biguanides; Alpha-glucosidase inhibitor delays starch, sucrose and maltose and be decomposed into glucose in small intestine, reduces postprandial blood sugar; Insulin sensitizer can improve the ability of utilizing insulin; Insulin and similar medicine thereof.These a few class medicines, to the ND of hyperglycaemia and are not suitable for all for diabetes.
The absorption of hyperglycaemia and high fat of blood and food has substantial connection, and has a big chunk crowd also not need to carry out drug therapy.Gu and by improving dietary structure, this type of disease can more effectively be alleviated or treat to the adjustment rule of life.
The present invention is comprised of daily bread, and apparent in view hypoglycemic lipid-lowering effect is arranged, and safe, is fit to have the patient of hyperglycaemia and high fat of blood as the diet replenishers.
By non-patent and the Searches of Patent Literature, search " a kind of biscuit with hypoglycemic, lipid-reducing function " of the patent No. 10999430.
Summary of the invention
The purpose of this invention is to provide a kind of composition with hypoglycemic lipid-lowering effect.
 
Soybean phytosterol:
Sterol refers to the organic matter take perhydrocyclopentanophenanthrene as skeleton, can be divided into animality sterol, plant sterols and bacterium property sterol.Animality take cholesterol as main; Vegetal sitosterol, stigmasterol and the campesterol etc. of being mainly; Bacterium property is mainly ergosterol.Human body is synthesizing phytosterol voluntarily, and absorption efficiency is not high yet, well below the absorptivity of cholesterol.This mainly is that the Phospholipids of human body etc. is more got close to cholesterol because the phytosterol dissolubility is poor.
The soybean phytosterol major part is demethlyate sterol, and wherein sitosterol, stigmasterol and campesterol account for more than 50%.Soybean phytosterol is the constituent of Various Tissues and cell, forms lipoprotein with protein bound, consists of the film of cell.
Relevant research data proves, phytosterol does not have obvious subacute toxicity and mutagenicity.
Physiological action:
1, soybean phytosterol has the effect that reduces serum cholesterol, reduces angiocardiopathy.
2, the soybean phytosterol security is very high, without subacute and mutagenicity effect.
 
Bitter buckwheat:
Bitter buckwheat is the polygonaceae plant hull buckwheat FagopyrumtataricumSeed, be a kind of medicine-food two-purpose crop of uniqueness, originate in the ground such as China and India, China mainly is distributed in loess plateau high and cold mountain area and mountain region, plateau, river, Yunnan-Guizhou.The Liangshan of Sichuan Province area is the main place of production of bitter buckwheat.
Its property is sweet, cold, the effect of have heat-clearing, promote the production of body fluid, quenching the thirst.Modern clinical research shows, bitter buckwheat has certain prophylactic treatment effect to obesity, diabetes, high fat of blood etc.
Relevant research data proves, bitter buckwheat does not have obvious acute toxicity and mutagenesis.
Physiological action:
1, the linoleic acid that enriches in the bitter buckwheat, vitamin, phytosterol, rutin, trace elements of selenium etc. have the effect of reducing blood sugar and blood fat.
2, bitter buckwheat reduces the inhibitory action to central nervous system by suppressing the formation of serotonin, and plays the effect of antifatigue.
3, bitter buckwheat has weak estrogen-like action because containing flavone compound.
4, bitter buckwheat has obvious protective effect to the chemical damage mouse.
5, bitter buckwheat has the enhancing activities of antioxidant enzymes, the effect of anti peroxidation of lipid.
 
The specific embodiment:
The invention will be further described by the following examples.
Embodiment: a kind of composition for hypoglycemic norcholesterol (powdery)
The present embodiment is selected bitter buckwheat, and the mixing soya beans phytosterol is filled a prescription by following raw material and consumption thereof.
The bitter buckwheat 1000 of soybean phytosterol 0.1-50
The bitter buckwheat of above-mentioned raw materials is mixed with soybean phytosterol, and the rear drying that stirs shatters rear mistake 60 mesh sieves, makes powdery.Brew with boiling water and to drink.

Claims (3)

1. a composition that is used for hypoglycemic norcholesterol is characterized in that, this prescription is comprised of soybean phytosterol and bitter buckwheat.
2. as claimed in claim 1, a kind of composition for hypoglycemic norcholesterol is characterized in that, the ratio in this prescription is:
The bitter buckwheat 1000 of soybean phytosterol 0.1-50.
3. a composition that is used for hypoglycemic norcholesterol is characterized in that, this prescription can be used for people with hyperlipidemia.
CN2011102249814A 2011-08-08 2011-08-08 Dietary supplement for lowering blood sugar and lowering cholesterol Pending CN102919849A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011102249814A CN102919849A (en) 2011-08-08 2011-08-08 Dietary supplement for lowering blood sugar and lowering cholesterol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011102249814A CN102919849A (en) 2011-08-08 2011-08-08 Dietary supplement for lowering blood sugar and lowering cholesterol

Publications (1)

Publication Number Publication Date
CN102919849A true CN102919849A (en) 2013-02-13

Family

ID=47634894

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011102249814A Pending CN102919849A (en) 2011-08-08 2011-08-08 Dietary supplement for lowering blood sugar and lowering cholesterol

Country Status (1)

Country Link
CN (1) CN102919849A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106235312A (en) * 2016-08-02 2016-12-21 宝健(北京)生物技术有限公司 A kind of compositions controlling cholesterol and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1203756A (en) * 1998-07-15 1999-01-06 段首中 Method for preparing blood fat-reducing blood sugar-reducing powder and its product
WO2005104864A1 (en) * 2004-04-28 2005-11-10 Unilever N.V. Edible oil containing statins
CN101869129A (en) * 2010-06-02 2010-10-27 李革田 Nutritional grain powder
CN101999430A (en) * 2010-11-10 2011-04-06 西藏天麦力健康品有限公司 Biscuit with blood sugar reducing and blood fat reducing functions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1203756A (en) * 1998-07-15 1999-01-06 段首中 Method for preparing blood fat-reducing blood sugar-reducing powder and its product
WO2005104864A1 (en) * 2004-04-28 2005-11-10 Unilever N.V. Edible oil containing statins
CN101869129A (en) * 2010-06-02 2010-10-27 李革田 Nutritional grain powder
CN101999430A (en) * 2010-11-10 2011-04-06 西藏天麦力健康品有限公司 Biscuit with blood sugar reducing and blood fat reducing functions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
四川成都润华堂制药有限公司: "苦荞茶 植物甾醇", 《HTTP://WWW.REINHERB.COM/PRO-SHOW.ASP?INFOID=761》, 21 September 2009 (2009-09-21) *
蒋培珍,等: "苦荞营养粉的保健功能研究", 《中国食品卫生杂志》, vol. 11, no. 4, 31 December 1999 (1999-12-31), pages 21 - 24 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106235312A (en) * 2016-08-02 2016-12-21 宝健(北京)生物技术有限公司 A kind of compositions controlling cholesterol and preparation method thereof
CN106235312B (en) * 2016-08-02 2019-08-06 宝健(北京)生物技术有限公司 A kind of composition and preparation method thereof controlling cholesterol

Similar Documents

Publication Publication Date Title
CN1956734A (en) Multi-vitamin and mineral nutritional supplements
CN102948483B (en) Blood fat reducing milk powder and preparation method thereof
JP2009077696A (en) Food containing extract of salacia plant and flavonoid
CN1957971A (en) Health products for decreasing blood fat
CN106036342A (en) Dietary supplement solid beverage suitable for diabetic population and preparation method of dietary supplement solid beverage
AU2017262874A1 (en) Gynostemma pentaphyllum containing health care pharmaceutical composition for preventing hyperlipidemia, hypertension, hyperglycemia, and gout
CN101766274B (en) Antioxidant functional food composition containing bamboo-leaves flavones
KR20120003693A (en) Anti-obesity composition comprising red grape extracts, green tea extracts, soybean extracts, and l-carnitine
CN101269061A (en) Methoxy flavonoid compound as medicament for preventing and controlling metabolism complex disease and using method
CN1305405C (en) Health food with subsidiary function of lowering blood sugar and lowering blood fat and its production process
CN104106828A (en) Solid beverage for reducing blood glucose
KR20100109697A (en) Functional composition with the effects of improving hyperlipidemia and reducing body weight
CN103083440A (en) Multi-functional natural healthcare product
KR20100003045A (en) Composition for preventing or improving diabete comprising sun-dried salt and an extract of eclipta prostrata
CN102475344A (en) Erythritol liver-protecting and stomach-invigorating health beverage and its preparation method
CN105878801A (en) Red kojic rice astaxanthin composition with blood lipid lowering effect
CN102919849A (en) Dietary supplement for lowering blood sugar and lowering cholesterol
CN106266811B (en) A kind of Chinese medicine composition and its preparation method and application for improving chemical damage
CN105535624A (en) Nutrition preparation for relieving cardiovascular and cerebrovascular diseases and preparation method thereof
CN104997018A (en) Yew enzyme health-care product as well as preparation method and application thereof
CN104666564A (en) Schisandra chinensis-oyster dealcoholic liver-protecting health medicine and preparation method thereof
CN104000877A (en) Blood glucose reducing composition and application thereof
CN104379214A (en) Kudzu and phytosterols for use in the treatment of metabolic disorders
KR101391647B1 (en) Anti obesity composition
CN102526198A (en) Medicine with cinnamon and chromium as additives and preparation method for health care product

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Free format text: FORMER OWNER: TIAN XI

Effective date: 20130912

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20130912

Address after: 611130 Yongkang Road, Wenjiang District, Sichuan, No. 688, No.

Applicant after: Yongkang Pharmaceutical Co., Ltd., Chengdu

Address before: 611130 Yongkang Road, Wenjiang District, Sichuan, No. 688, No.

Applicant before: Yongkang Pharmaceutical Co., Ltd., Chengdu

Applicant before: Tian Xi

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20130213